Blood-based molecular signal may detect pre-cancerous ovarian lesions

Researchers report a blood biomarker that can identify tubal intraepithelial carcinoma, a precursor to high-grade serous ovarian cancer, potentially enabling earlier detection. The finding is preliminary and not yet clinically validated; its sensitivity and specificity remain unknown. If confirmed, it could shift ovarian cancer screening from late-stage diagnosis to early intervention.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works